Recovery & DOMS Support

B84· Mostly solid

Public • 04 Feb 2026

Supports post-training soreness reduction & recovery.

← Back Try alternative layout

Buy stack

Recovery & DOMS Support

recovery sleep muscle

Curcumin Extract

Daily

MODERATE

1000mg

Magnesium (Glycinate)

Daily

MODERATE

400mg

No interactions detected

Each dose includes evidence rationale · doses personalized to your weight

Stack note

Private note on this stack

Track how this stack felt, what you want to change next cycle, or anything you want to save privately in your member zone.

AI risk assessment

Context: No wearable data

PROAI risk assessment is available with Pro.

See plans

Stack pre-check

No personal data connected — connect wearables or upload bloodwork for a personalised check

Clean

Supplements

Training load

Unknown

No flags

No duplication, stimulant, interaction, or recovery concerns detected.

Pre-check is rule-based, not medical advice. Consult a healthcare professional for personalised guidance.

Interaction Analysis

Pharmacokinetic + pair-level checks

Timing optimizations

Curcumin Extract

Take ~2h before the intended effect window

Reaches peak plasma concentration in ~2h. Half-life ~8h.

Magnesium (Glycinate)

Evening (glycinate/threonate) or before bed

Magnesium promotes GABA activity and lowers core body temperature, aiding sleep onset and quality. (Onset: ~2h, half-life: ~8h)

Interaction analysis is based on peer-reviewed pharmacology. PMID links go to PubMed. Not medical advice.

Supplements

2 items

Curcumin ExtractModerate

Daily •

Buy ingredient →

1000mg

Systemic inflammation — CRP & high-sensitivity CRP reduction

Moderate

Population: Adults with pro-inflammatory conditions (various clinical populations)

Study type: Systematic review and meta-analysis of RCTs

Dose context: 1000 mg typical • Duration: >10 weeks

Curcumin supplementation significantly decreased CRP (WMD −3.67 mg/L, 95% CI −6.96 to −0.38) & hs-CRP vs placebo across 9 CRP & 23 hs-CRP trials; greatest effect at doses ≤1,000 mg/day & duration >10 weeks.

Citation: Gorabi AM, Abbasifard M, Imani D, et al. Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials. Phytother Res. 2022;36(1):85-97.•DOI: 10.1002/ptr.7284•https://pubmed.ncbi.nlm.nih.gov/34586711/

Non-linear dose-response; stronger effects with <2,000 mg/day curcumin.

Delayed-onset muscle soreness (DOMS) reduction after exercise

Moderate

Population: Healthy adults performing resistance or eccentric exercise

Study type: Systematic review and meta-analysis of RCTs

Dose context: —

Curcumin supplementation significantly reduced DOMS & muscle damage markers (CK, LDH) vs placebo; effect sizes were moderate & clinically meaningful for pain reduction in eccentric exercise protocols.

Citation: Beba M, et al. The effect of curcumin supplementation on delayed-onset muscle soreness, inflammation, muscle strength, and joint flexibility: a systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2022;36(7):2739-2753.•https://pubmed.ncbi.nlm.nih.gov/35574627/

Magnesium (Glycinate)Moderate

Daily •

Buy ingredient →

400mg

Trade-offs & context

Tolerance

Loose stools at higher doses; glycinate form is better tolerated than citrate or oxide

Context: doses >400mg elemental

Timing

Drowsiness — take in the evening to leverage rather than fight this effect

Sleep quality in adults with poor sleep (magnesium bisglycinate RCT)

Moderate

Population: Adults aged 18–65 with self-reported poor sleep (n=155)

Study type: RCT (double-blind, placebo-controlled)

Dose context: 250 mg typical (range: 200–250 mg) • Duration: 8 weeks

250 mg elemental magnesium as bisglycinate modestly but significantly reduced Insomnia Severity Index score vs. placebo (−3.9 vs −2.3, p=0.049) by week 4; well-tolerated with minimal GI effects.

Citation: Abboud M et al. Nutrients. 2025.•https://pubmed.ncbi.nlm.nih.gov/40918053/

First RCT specifically using magnesium bisglycinate for sleep in a general adult population.

Insomnia in older adults (sleep latency, total sleep time)

Low

Population: Older adults with insomnia (3 RCTs, n=151)

Study type: Systematic review & meta-analysis

Dose context: 320 mg typical (range: 100–500 mg) • Duration: 8 weeks

Magnesium supplementation reduced sleep onset latency by ~17 min vs. placebo; increased sleep time & efficiency. Evidence rated low-to-very-low quality; all trials at moderate-to-high bias risk.

Citation: Mah J & Pitre T. BMC Complement Med Ther. 2021;21(1):125.•DOI: 10.1186/s12906-021-03297-z•https://pubmed.ncbi.nlm.nih.gov/33865376/

Benefit most plausible in those with low baseline magnesium. Dose refers to elemental magnesium.